Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials
Minoru Miyashita, Masaya Hattori, Toshimi Takano, Tatsuya Toyama, Hiroji Iwata
Topics & Concepts
BevacizumabMedicineMetastatic breast cancerInternal medicineChemotherapyHazard ratioBreast cancerOncologyDiscontinuationRandomized controlled trialCochrane LibraryMeta-analysisCancerSurgeryConfidence intervalCancer Treatment and PharmacologyHER2/EGFR in Cancer ResearchAdvanced Breast Cancer Therapies